GLP1-SMG

GLP1-SG is APEX 100's research-gradeanalog—a 31-amino acid synthetic peptide that functions as a selective GLP-1 receptor agonist with a pharmacokinetic profile engineered for extended activity. Its C18 fatty acid chain, conjugated at position 26 via a linker, enables non-covalent albumin binding that dramatically extends the compound's half-life in preclinical models compared to native GLP-1. In published Phase III investigative research, GLP1-SG has generated among the largest and most diverse outcome datasets of any peptide in its class, with peer-reviewed literature spanning cardiovascular events, weight endpoints, renal function, and neurological signals.

This breadth of published research makes it an essential reference compound for incretin biology studies. APEX 100 sources GLP1-SG to ≥99% HPLC purity with independent mass spectrometry confirmation of molecular identity. Every vial ships with a full COA.

The lyophilized format is stable at -20°C and reconstitutes readily in bacteriostatic or sterile water.

For research and laboratory use only. Not for human consumption.